<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.8.4" -->
<rss version="0.92">
<channel>
	<title>Savira Pharmaceuticals</title>
	<link>http://www.savira.at</link>
	<description>Development of drugs for the treatment of influenza</description>
	<lastBuildDate>Fri, 16 Oct 2009 14:56:29 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>SAVIRA AMONG THE MOST PROMISING VIENNA START-UP COMPANIES</title>
		<description>Savira was awarded third place by the City of Vienna Future Award (Wiener Zukunftspreis 2009) in the category ‘Newcomer and Start-ups’. The Jury comprised top experts from various areas such as Markus Hengstschläger (Medical University of Vienna), Christoph Zielinski (Medical University of Vienna), Henrietta Egerth (FFG), Gabriele Zuna-Kratky (Technisches Museum ...</description>
		<link>http://www.savira.at/499/savira-among-the-most-promising-vienna-start-up-companies/</link>
			</item>
	<item>
		<title>FOUNDATION OF SAVIRA PHARMACEUTICALS GMBH</title>
		<description> 
 
SAVIRA PHARMACEUTICALS– Defeating Influenza
onepharm and EMBL establish new company with the help of AWS. Focus on development of novel anti-influenza drugs
 
Vienna, 23.9.2009 – Savira, an Austrian pharmaceutical company focusing on the development of novel anti-influenza drugs was recently established in Vienna and supported with seed financing of 1 Mio ...</description>
		<link>http://www.savira.at/149/foundation-of-savira-pharmaceuticals-gmbh/</link>
			</item>
</channel>
</rss>
